219 related articles for article (PubMed ID: 31127272)
41. A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.
Kumar S; Nadeem S; Stan MN; Coenen M; Bahn RS
J Mol Endocrinol; 2011 Jun; 46(3):155-63. PubMed ID: 21321093
[TBL] [Abstract][Full Text] [Related]
42. A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves' orbitopathy.
Cui X; Wang F; Liu C
Front Immunol; 2023; 14():1062045. PubMed ID: 36742308
[TBL] [Abstract][Full Text] [Related]
43. TSH-Mediated TNFα Production in Human Fibrocytes Is Inhibited by Teprotumumab, an IGF-1R Antagonist.
Chen H; Shan SJ; Mester T; Wei YH; Douglas RS
PLoS One; 2015; 10(6):e0130322. PubMed ID: 26087256
[TBL] [Abstract][Full Text] [Related]
44. Increased expression of TSH receptor by fibrocytes in thyroid-associated ophthalmopathy leads to chemokine production.
Gillespie EF; Papageorgiou KI; Fernando R; Raychaudhuri N; Cockerham KP; Charara LK; Goncalves AC; Zhao SX; Ginter A; Lu Y; Smith TJ; Douglas RS
J Clin Endocrinol Metab; 2012 May; 97(5):E740-6. PubMed ID: 22399514
[TBL] [Abstract][Full Text] [Related]
45. Thyrotropin Receptor Antagonism by a Novel Small Molecule: Preclinical
Kahaly GJ; Steiner L; van der Lee MMC; van Achterberg TAE; Arends RJ; Karstens WFJ; Weirauch T; Henseling J; Frommer L; Wolf J; George A
Thyroid; 2023 Jun; 33(6):732-742. PubMed ID: 37016815
[No Abstract] [Full Text] [Related]
46. Beta-Arrestin 1 Mediates Liver Thyrotropin Regulation of Cholesterol Conversion Metabolism via the Akt-Dependent Pathway.
Niu S; Li H; Chen W; Zhao J; Gao L; Bo T
Int J Endocrinol; 2018; 2018():4371396. PubMed ID: 29853881
[TBL] [Abstract][Full Text] [Related]
47. A New Highly Thyrotropin Receptor-Selective Small-Molecule Antagonist with Potential for the Treatment of Graves' Orbitopathy.
Marcinkowski P; Hoyer I; Specker E; Furkert J; Rutz C; Neuenschwander M; Sobottka S; Sun H; Nazare M; Berchner-Pfannschmidt U; von Kries JP; Eckstein A; Schülein R; Krause G
Thyroid; 2019 Jan; 29(1):111-123. PubMed ID: 30351237
[TBL] [Abstract][Full Text] [Related]
48. Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy.
Dik WA; Virakul S; van Steensel L
Exp Eye Res; 2016 Jan; 142():83-91. PubMed ID: 26675405
[TBL] [Abstract][Full Text] [Related]
49. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
[TBL] [Abstract][Full Text] [Related]
50. Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1.
Ma Z; Yu YR; Badea CT; Kovacs JJ; Xiong X; Comhair S; Piantadosi CA; Rajagopal S
Circulation; 2019 Mar; 139(13):1629-1642. PubMed ID: 30586762
[TBL] [Abstract][Full Text] [Related]
51. Expression and regulation of G protein-coupled receptor kinase 5 and beta-arrestin-1 in rat thyroid FRTL5 cells.
Nagayama Y; Tanaka K; Namba H; Yamashita S; Niwa M
Thyroid; 1996 Dec; 6(6):627-31. PubMed ID: 9001199
[TBL] [Abstract][Full Text] [Related]
52. The human thyrotropin receptor is predominantly internalized by beta-arrestin 2.
Frenzel R; Voigt C; Paschke R
Endocrinology; 2006 Jun; 147(6):3114-22. PubMed ID: 16513835
[TBL] [Abstract][Full Text] [Related]
53. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin.
Bahn RS; Dutton CM; Joba W; Heufelder AE
Thyroid; 1998 Feb; 8(2):193-6. PubMed ID: 9510130
[TBL] [Abstract][Full Text] [Related]
54. Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction.
Zhang L; Bowen T; Grennan-Jones F; Paddon C; Giles P; Webber J; Steadman R; Ludgate M
J Biol Chem; 2009 Sep; 284(39):26447-55. PubMed ID: 19633293
[TBL] [Abstract][Full Text] [Related]
55. A Gq Biased Small Molecule Active at the TSH Receptor.
Latif R; Morshed SA; Ma R; Tokat B; Mezei M; Davies TF
Front Endocrinol (Lausanne); 2020; 11():372. PubMed ID: 32676053
[TBL] [Abstract][Full Text] [Related]
56. Pentraxin-3 Is a TSH-Inducible Protein in Human Fibrocytes and Orbital Fibroblasts.
Wang H; Atkins SJ; Fernando R; Wei RL; Smith TJ
Endocrinology; 2015 Nov; 156(11):4336-44. PubMed ID: 26287404
[TBL] [Abstract][Full Text] [Related]
57. Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization.
Neumann S; Geras-Raaka E; Marcus-Samuels B; Gershengorn MC
FASEB J; 2010 Oct; 24(10):3992-9. PubMed ID: 20538910
[TBL] [Abstract][Full Text] [Related]
58. TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.
Smith TJ
Nat Rev Endocrinol; 2015 Mar; 11(3):171-81. PubMed ID: 25560705
[TBL] [Abstract][Full Text] [Related]
59. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22.
Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR
Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151
[TBL] [Abstract][Full Text] [Related]
60. Biased signaling by thyroid-stimulating hormone receptor-specific antibodies determines thyrocyte survival in autoimmunity.
Morshed SA; Ma R; Latif R; Davies TF
Sci Signal; 2018 Jan; 11(514):. PubMed ID: 29363585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
